STERIS (NYSE:STE) Price Target Raised to $284.00
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
KeyCorp has raised its price target for STERIS (NYSE:STE) to $284.00 from $269.00, maintaining an "overweight" rating and suggesting a 13.4% upside. This follows STERIS's strong quarterly performance, where the company exceeded EPS and revenue expectations. Analyst sentiment is generally positive, with a "Moderate Buy" consensus and an average target price of $276.33.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.